pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Hemophilia A
drug
save

Hemophilia A

Preclinicalupdated 5mo ago
by Sernova Biotherapeutics Inc
Preclinical
community read0 votes

🐶 often sniffed alongside

top 7
  • tagHemophilia5 co-mentions · 3 sources
  • companyAltasciences Co Inc1 co-mentions · 1 sources
  • drugefanesoctocog alfa1 co-mentions · 1 sources
  • tagCRO/CDMO1 co-mentions · 1 sources
  • drugicosapent ethyl1 co-mentions · 1 sources
  • drugNN-74421 co-mentions · 1 sources
  • companyPSI CRO AG1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

News(5)

  • CHMP backs Novo’s hemophilia A drug and seven other medicines
    Novo won regulatory backing for its hemophilia A preventive drug from the European Medicines Agency's human medicines committee, which also recommended approving seven other new drugs and 11 label…
    endpoints · 12d ago
  • Roche, Dualitas team up to find bispecific drugs for immune diseases
    Through a research deal worth up to $1 billion, Dualitas will sift through more than 300,000 possible bispecific combinations in the hopes of unearthing new and differentiating treatments.
    biopharma_dive · 13d ago
  • Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive
    Roche is paying Dualitas Therapeutics $36.5 million upfront to screen over 300,000 novel bispecific combinations in search of new treatments for immunology and inflammation diseases.
    fiercebiotech · 13d ago
  • Oz says ‘AI-based avatars’ can help rural communities. Some leaders disagree
    Feds invest in AI for heart failure, vaccines and this year's midterms, and more health news from Morning Rounds
    stat · 20d ago
  • Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add on
    Roche has 19 investigational medicines that could launch by 2030—and even if not all of them make it to market, the company is “well set-up for growth into the next decade,” CEO Thomas Schinecker s…
    biospace · 2mo ago
indication
Hemophilia A (Factor VIII Deficiency)
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 33m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?